LeadMD is the #1 performance marketing consultancy that leverages best-in-class technology to make your vision actionable and your outcomes measurable. Breaking down the typical siloes of technology and strategy, LeadMD collaborates with clients to increase revenues, align teams and engage ideal customers. We’ve helped more than 3,500 high-growth companies succeed by building revenue engines that scale on top of marketing and sales platforms like Marketo , Adobe, Salesforce.com and dozens of others.

C-Suite On Deck

Andrea Lechner-Becker, Chief Marketing Officer at LeadMD is an experienced Marketing and Sales Executive with a demonstrated history of working in the marketing and advertising industry.

Skilled in Business Process, Marketo, Sales, Customer Relationship Management (C...

Events

Related News

MEDICAL

GT MOLECULAR, RAPIDLY EXPANDING MOLECULAR DIAGNOSTICS BIOTECH, LAUNCHES TWO HIGHLY SENSITIVE TESTS FOR THE DANGEROUS UK VARIANT OF SARS-COV-2

GT Molecular | January 13, 2021

news image

GT Molecular, a quickly extending sub-atomic diagnostics biotech, has dispatched two profoundly delicate tests for the risky UK Variant of SARS-CoV-2 (B.1.1.7). These tale examines expand upon GT Molecular's clinical foundation and technology for profoundly exact and solid qPCR and advanced PCR recognition of SARS-CoV-2 virus and are offered in two formats. The fee-for-service testing of wastewater for the presence of SARS-CoV-2 and the variations available for use furnishes n...

Read More

CELL AND GENE THERAPY, INDUSTRIAL IMPACT

CBM ANNOUNCES PARTNERSHIP WITH VIRION THERAPEUTICS

Center for Breakthrough Medicines | February 27, 2023

news image

Center for Breakthrough Medicines (CBM), a leading contract development and manufacturing organization dedicated to addressing the challenges of commercializing cell and gene therapies, and Virion Therapeutics, a clinical-stage biotech firm focused on developing accessible and adaptable CD8+ T cell-based technologies for cancer and infectious diseases, have recently announced a strategic collaboration agreement. CBM will partner and manufacture with Virion Therapeutics on their ...

Read More

MEDTECH

BIONAUT LABS CLOSES $43M IN SERIES B LED BY KHOSLA VENTURES TO ADVANCE FIRST-IN-CLASS MICRO-ROBOTIC TECHNOLOGY AND REMOVE BARRIERS

Bionaut Labs | November 29, 2022

news image

Bionaut Labs, the company that uses microscale robots to revolutionize the treatment of central nervous system diseases and disorders, announced $43.2M in a Series B round of financing led by Khosla Ventures, bringing the company’s total financing raised to date to $63.2 million. Also participating in the round are new investors Deep Insight, OurCrowd, PSPRS, Sixty Degree Capital, Dolby Family Ventures, GISEV Family Ventures, What if Ventures, Tintah Grace and Gaingels, along with all exis...

Read More

NOVARTIS TAPS ORIONIS TO PURSUE 'HISTORICALLY ELUSIVE TARGETS'

FierceBiotech | March 06, 2020

news image

Novartis has entered into a four-year research collaboration with Orionis Biosciences. The agreement tasks Orionis with applying its technologies to “historically elusive targets” in multiple therapeutic areas. Orionis has been around since 2015 but kept a low profile over most of that time. The transatlantic biotech used its time flying below the radar to establish two platforms, one focused on cytokines and another for “genome-scale drug discovery,” and to use them to g...

Read More
news image

MEDICAL

GT MOLECULAR, RAPIDLY EXPANDING MOLECULAR DIAGNOSTICS BIOTECH, LAUNCHES TWO HIGHLY SENSITIVE TESTS FOR THE DANGEROUS UK VARIANT OF SARS-COV-2

GT Molecular | January 13, 2021

GT Molecular, a quickly extending sub-atomic diagnostics biotech, has dispatched two profoundly delicate tests for the risky UK Variant of SARS-CoV-2 (B.1.1.7). These tale examines expand upon GT Molecular's clinical foundation and technology for profoundly exact and solid qPCR and advanced PCR recognition of SARS-CoV-2 virus and are offered in two formats. The fee-for-service testing of wastewater for the presence of SARS-CoV-2 and the variations available for use furnishes n...

Read More
news image

CELL AND GENE THERAPY, INDUSTRIAL IMPACT

CBM ANNOUNCES PARTNERSHIP WITH VIRION THERAPEUTICS

Center for Breakthrough Medicines | February 27, 2023

Center for Breakthrough Medicines (CBM), a leading contract development and manufacturing organization dedicated to addressing the challenges of commercializing cell and gene therapies, and Virion Therapeutics, a clinical-stage biotech firm focused on developing accessible and adaptable CD8+ T cell-based technologies for cancer and infectious diseases, have recently announced a strategic collaboration agreement. CBM will partner and manufacture with Virion Therapeutics on their ...

Read More
news image

MEDTECH

BIONAUT LABS CLOSES $43M IN SERIES B LED BY KHOSLA VENTURES TO ADVANCE FIRST-IN-CLASS MICRO-ROBOTIC TECHNOLOGY AND REMOVE BARRIERS

Bionaut Labs | November 29, 2022

Bionaut Labs, the company that uses microscale robots to revolutionize the treatment of central nervous system diseases and disorders, announced $43.2M in a Series B round of financing led by Khosla Ventures, bringing the company’s total financing raised to date to $63.2 million. Also participating in the round are new investors Deep Insight, OurCrowd, PSPRS, Sixty Degree Capital, Dolby Family Ventures, GISEV Family Ventures, What if Ventures, Tintah Grace and Gaingels, along with all exis...

Read More
news image

NOVARTIS TAPS ORIONIS TO PURSUE 'HISTORICALLY ELUSIVE TARGETS'

FierceBiotech | March 06, 2020

Novartis has entered into a four-year research collaboration with Orionis Biosciences. The agreement tasks Orionis with applying its technologies to “historically elusive targets” in multiple therapeutic areas. Orionis has been around since 2015 but kept a low profile over most of that time. The transatlantic biotech used its time flying below the radar to establish two platforms, one focused on cytokines and another for “genome-scale drug discovery,” and to use them to g...

Read More

Resources

Events

C-Suite On Deck

Andrea Lechner-Becker, Chief Marketing Officer at LeadMD is an experienced Marketing and Sales Executive with a demonstrated history of working in the marketing and advertising industry.

Skilled in Business Process, Marketo, Sales, Customer Relationship Management (C...